MedMira Inc (MMIRF PINK) stock market data APIs
$0.0133
0(0%)
as of February 13, 2026
Try our APIs with
free plan!
MedMira Inc Financial Data Overview
Price chart is built with
Anychart
MedMira Inc., a biotechnology company, researches, develops, manufactures, and sells rapid diagnostics and technology platforms in North America, Europe, and internationally. The company offers Reveal HIV, a test that detects antibodies to HIV-1 and HIV-2 in whole blood, serum, or plasma; Reveal TP, a rapid syphilis antibody test that detects treponema pallidum antibodies in serum, plasma, or whole blood; Multiplo, a line of multiplex tests for HIV-1/2, Hepatitis B and C, and syphilis; and Miriad triple product for preliminary screening of HIV and hepatitis. It also provides the Miriad RVF toolkit, which facilitates the development and commercialization of rapid diagnostics; and Reveal G4 HIV tests. The company was founded in 1993 and is headquartered in Halifax, Canada. MedMira Inc. is a subsidiary of MedMira Holding AG.
Prev. Close
0.0133
Open
0.0133
High
0.0133
Low
0.0133
52 wk Range
0.012-0.1
Market Cap
9 276 K
Shares Outstanding
697 M
Revenue
233 K
EPS
-0.0008
Beta
0.662
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get MedMira Inc data using free add-ons & libraries
Get MedMira Inc Fundamental Data
MedMira Inc Fundamental data includes:
- Net Revenue: 233 K
- EBITDA: -3 085 504
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-12-29
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
MedMira Inc News
New
Medmira reports Q2 results
* Medmira press release [https://seekingalpha.com/pr/20152729-medmira-reports-second-quarter-results-fy2025] (OTCPK:MMIRF [https://seekingalpha.com/symbol/MMIRF]): Q2 Revenues in Q2 FY2025 of C$69,...
MedMira Reports Third Quarter Results FY2023
HALIFAX, NS / ACCESSWIRE / June 29, 2023 / MedMira Inc. (MedMira) (TSXV:MIR), reported today on its financial results for the quarter ended April 30, 2023. Corporate Update Summary During the third ...
MedMira Second Quarter 2023 Earnings: CA$0.001 loss per share (vs CA$0.001 loss in 2Q 2022)
MedMira (CVE:MIR) Second Quarter 2023 Results Key Financial Results Revenue: CA$170.5k (down 43% from 2Q 2022). Net loss: CA$490.5k (loss widened by 4.7% from 2Q 2022). CA$0.001 loss per share (in l...
MedMira Reports Second Quarter Results FY2023
HALIFAX, NS / ACCESSWIRE / April 3, 2023 / MedMira Inc. (MedMira) (TSXV:MIR), reported today on its financial results for the quarter ended January 31, 2023. Corporate Update Summary During the seco...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
